Since Tregs are responsible for maintaining immune tolerance and suppressing excessive immune responses,[20] enhancing CD4 signaling or utilizing CD4 agonists may improve antitumor immunity against meningioma.[21] CD25++ plays a critical role in T cell activation and proliferation and may be associated with tumor cell proliferation and survival capacity. The gene discussed is CD4; the disease is neoplasm.